Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Facebook, Inc. v. Windy City Innovations, LLC, Appeal Nos. 2018-1400 et al. (Fed. Cir. Sept. 4, 2020)
The only precedential decision this week was a modified panel decision of a prior precedential opinion following a petition for rehearing or rehearing en banc. The en banc court declined to take the matter.
In short, after Facebook was sued for infringement, it petitioned for IPRs. But the complaint did not specify which of the more than 800 claims of those patents were allegedly infringed. Facebook challenged some, but not all, of the claims. More than a year later, Windy City identified its infringement allegations, which included some claims that Facebook had not challenged in its IPRs. Facebook filed two new petitions for IPRs of those claims along with motions to join them to the existing IPRs. The Board granted the motion for joinder and terminated the two new IPRs. The primary issues were whether a party can later join itself to an IPR that it had previously filed, and whether a party can add new claims to an existing IPR through joinder when those claims would otherwise be time-barred. The Federal Circuit concluded, with respect to both, that it could not. We covered the original decision as our Case of the Week on March 23, 2020.
Read More.
By: Nika F. Aldrich
Edited by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…